Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic

By Yahoo! Finance | Nov 4, 2024 at 05:37 AM EST

CorMedix Inc. (CRMD) shareholders are optimistic as analysts upgraded revenue and earnings forecasts for next year. Predicted revenues for 2025 are $111m, and EPS is estimated at $0.45. Despite the positive outlook, the stock's price target remains at $14.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.